Arbeitspapier

Determinants of pharmaceutical innovation: The role of technological opportunities revisited

Recent empirical contributions emphasize the importance of (potential) market size for the development of new pharmaceuticals. At the same time many scholars point out the importance of of scientific advances for the industry's R&D activities. Against this background I analyze the relationship between (potential) market size, technological opportunities, and the number of new pharmaceuticals in the United States. Technological opportunities are operationalized as growth rates of the relevant knowledge stock as proposed by Andersen (1999, 1998). I analyze a unique dataset by using an entry stock Poisson quasi-maximum likelihood estimator. The results reveal a rather robust and significantly positive response of the number of new pharmaceuticals, i.e., new molecular entities or new drug approvals, to market size and technological opportunities.

Sprache
Englisch

Erschienen in
Series: Jena Economic Research Papers ; No. 2012,018

Klassifikation
Wirtschaft
Innovation and Invention: Processes and Incentives
Demographic Economics: General
Demand and Supply of Labor: General
Thema
Determinants of Innovation
Pharmaceuticals
Demand
Technological Opportunities
Pharmazeutische Forschung
Produktinnovation
Arzneimittelmarkt
Technischer Fortschritt
USA

Ereignis
Geistige Schöpfung
(wer)
Rake, Bastian
Ereignis
Veröffentlichung
(wer)
Friedrich Schiller University Jena and Max Planck Institute of Economics
(wo)
Jena
(wann)
2012

Handle
Letzte Aktualisierung
10.03.2025, 11:43 MEZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.

Objekttyp

  • Arbeitspapier

Beteiligte

  • Rake, Bastian
  • Friedrich Schiller University Jena and Max Planck Institute of Economics

Entstanden

  • 2012

Ähnliche Objekte (12)